|NanoViricides, Inc. (NNVC): A typical nanoviricides drug is designed like a chemical missile. It has a number of recognition "ligands" on its surface, that are specific to a single type of virus, say HIV. They are like the GPS on a directed missile. They will identify the enemy and attach to specific "landing sites" on the enemy target. The nanoviricides drug, after landing, spreads itself all over the virus particle, and thus completely neutralizes and disables the virus particle from binding to its target, a human cell.|
Patents: Solubilization and Targeted Delivery of Drugs with Selfassembling Amphiphilic Polymers -
WIPO application - tinyurl.com
INPADOC patent family - is.gd
USPTO application - is.gd
USPTO PDF - patent2pdf.com
The targets: We currently have, in early, active development, products against H5N1 (Avian Flu), common Human Influenza (both highly pathogenic and non pathogenic), Rabies, and Hepatitis C. We plan on undertaking the development of drugs against other viruses when adequate financing becomes available.
cGMP facility : 18,000 square foot building on a 4 acre lot at 1 Controls Drive in Shelton Connecticut enabling future expansion of operations.
Google Maps: is.gd